Susquehanna International Group’s Genesis Healthcare, Inc. GEN Stock Holding History

Susquehanna International Group’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-35,000	Closed	-$50K	–	11117
2019 Q1	$50K	Buy	35,000 +6,000	+21%	+$8.9K	﹤0.01%	8463
2018 Q4	$34K	Buy	+29,000	New	+$43K	﹤0.01%	8590
2018 Q3	–	Sell	-14,000	Closed	-$32K	–	10635
2018 Q2	$32K	Sell	14,000 -1,700	-11%	-$3.28K	﹤0.01%	9363
2018 Q1	$24K	Buy	+15,700	New	+$18.4K	﹤0.01%	9104
2017 Q2	–	Sell	-17,400	Closed	-$46K	–	10111
2017 Q1	$46K	Sell	17,400 -22,200	-56%	-$79.7K	﹤0.01%	8616
2016 Q4	$168K	Buy	39,600 +6,900	+21%	+$22.7K	﹤0.01%	8783
2016 Q3	$87K	Buy	+32,700	New	+$75.2K	﹤0.01%	7995
2015 Q2	–	Sell	-25,300	Closed	-$180K	–	10621
2015 Q1	$180K	Buy	+25,300	New	+$191K	﹤0.01%	8701

Other funds holding GEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group's GEN Position: Q2 2020 in Review

Susquehanna International Group sold out of Genesis Healthcare, Inc. (GEN) in Q2 2020, closing a stake of 24,960 shares — an estimated $21K sold.

Susquehanna International Group first reported a position in GEN in Q1 2015 and held it in 10 quarters. The position peaked at $157K in Q4 2016. 58 funds tracked by Wall St. Rank hold GEN as of Q2 2020.

Susquehanna International Group reported no remaining Genesis Healthcare, Inc. position as of Q2 2020 after selling out during the quarter.
Susquehanna International Group sold 24,960 Genesis Healthcare, Inc. shares in Q2 2020, an estimated $21K.
Susquehanna International Group first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 10 quarters.
Susquehanna International Group's Genesis Healthcare, Inc. position peaked at $157K in Q4 2016.
58 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.